DcpS as a therapeutic target for spinal muscular atrophy.
Singh, J., Salcius, M., Liu, S.W., Staker, B.L., Mishra, R., Thurmond, J., Michaud, G., Mattoon, D.R., Printen, J., Christensen, J., Bjornsson, J.M., Pollok, B.A., Kiledjian, M., Stewart, L., Jarecki, J., Gurney, M.E.(2008) Acs Chem.Biol. 3: 711-722
- PubMed: 18839960 
- DOI: 10.1021/cb800120t
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene, which produces an essential protein known as SMN. The severity of SMA is modified by variable copy number of a second gene,SMN2, which produces an mRNA t ...